FDA approves new ALS drug tested in clinical trial at UF
AMX0035 was tested at UF, Mass General and partnering sites and then approved by the FDA to treat ALS.
Posts tagged as
James Wymer
A gift of fate and purpose
Learn how a new fund is propelling the ALS research of Drs. Emily Plowman and James Wymer.
Researchers report experimental drug may prolong survival in ALS patients
Trial drug combination shows potential to prolong survival of ALS patients by more than six months.
New trial drug combination shows promise for slowing progression of ALS
UF was the No. 2 enroller of patients for multisite ALS trial.
New study reveals treatment pathway for neurofibromatosis
Dr. James Wymer among national team of researchers to identify novel pathway for potential treatment of the disfiguring condition, neurofibromatosis 1.
Three neurology faculty members honored with professorships
The seventh annual 2018 Celebrating Distinction event honored faculty named to endowed professorships, chairs.
Dr. James Wymer discusses ALS
Following legendary physicist Stephen Hawking’s passing after battling ALS for more than 50 years, Dr. James Wymer discusses this unforgiving disease.
